Data gathered: November 27
Alternative Data for Liquidia
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | N/A | Sign up | Sign up | Sign up |
| Sentiment | 70 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 2 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 3,711 | Sign up | Sign up | Sign up |
| Twitter Followers | 946 | Sign up | Sign up | Sign up |
| Twitter Mentions | 9 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 39 | Sign up | Sign up | Sign up |
| Linkedin Employees | 162 | Sign up | Sign up | Sign up |
About Liquidia
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.
| Price | $11.62 |
| Target Price | Sign up |
| Volume | 341,250 |
| Market Cap | $952M |
| Year Range | $8.9 - $16.73 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Wall Street Analysts See a 126.13% Upside in Liquidia Technologies (LQDA): Can the Stock Really Move This High?November 25 - Yahoo |
 |
Liquidia Co. (NASDAQ:LQDA) Receives $24.00 Average Target Price from BrokeragesNovember 24 - ETF Daily News |
|
FY2024 EPS Estimates for Liquidia Boosted by HC WainwrightNovember 17 - ETF Daily News |
 |
Liquidia Third Quarter 2024 Earnings: Beats ExpectationsNovember 14 - Yahoo |
 |
Liquidia Corporation: Resilience In The Face Of Formidable Opposition Can Pay OffNovember 14 - SeekingAlpha |
 |
Liquidia Corp (LQDA) Q3 2024 Earnings Call Highlights: Strategic Advances Amidst Regulatory ...November 13 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 8.7M | 22M | -13M | -23M | -29M | 0.000 |
| Q2 '24 | 1.1M | 22M | -21M | -28M | -27M | -0.370 |
| Q1 '24 | 3M | 22M | -33M | -41M | -29M | -0.540 |
| Q4 '23 | 2.6M | 18M | -16M | -27M | -26M | -0.420 |
| Q3 '23 | 1.9M | 11M | -9.5M | -16M | -15M | -0.240 |
Insider Transactions View All
| Adair Jason filed to sell 118,115 shares at $11.3. October 29 '24 |
| Adair Jason filed to sell 118,115 shares at $11.3. November 20 '24 |
| Saggar Rajeev filed to sell 204,857 shares at $11.2. October 22 '24 |
| Adair Jason filed to sell 118,574 shares at $11.1. October 15 '24 |
| JEFFS ROGER filed to sell 812,193 shares at $11.1. October 15 '24 |
Similar companies
Read more about Liquidia (LQDA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Liquidia?
The Market Cap of Liquidia is $952M.
What is the current stock price of Liquidia?
Currently, the price of one share of Liquidia stock is $11.62.
How can I analyze the LQDA stock price chart for investment decisions?
The LQDA stock price chart above provides a comprehensive visual representation of Liquidia's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Liquidia shares. Our platform offers an up-to-date LQDA stock price chart, along with technical data analysis and alternative data insights.
Does LQDA offer dividends to its shareholders?
As of our latest update, Liquidia (LQDA) does not offer dividends to its shareholders. Investors interested in Liquidia should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Liquidia?
Some of the similar stocks of Liquidia are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.